echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > List of medical events in September: ranking of R & D and net profit in the first half of the year

    List of medical events in September: ranking of R & D and net profit in the first half of the year

    • Last Update: 2019-10-02
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network industry trends 】Since September, the transcripts of listed enterprises in the first half of 2019 have been basically disclosed Along with the business performance, there are also lists of R & D investment and net profit of pharmaceutical enterprises While summarizing the situation in the first half of 2019, these lists also have more reference value, and provide more impetus for the development of listed enterprises, so as to make their next development more credible Heart The list of pharmaceutical companies' earning power came out With the disclosure of the performance of Listed Companies in the first half of 2019 coming to an end, according to the statistics of an institution, among the 289 pharmaceutical companies (including pharmaceutical manufacturing and medical industry) in a share, 19 pharmaceutical companies such as Cr 39, Sihuan biology, Haizheng pharmaceutical and Ma Yinglong had a net profit growth rate of more than 100% in the first half of the year Among them, the net profits of Baiyunshan, Hengrui medicine, Meirui medicine, Shanghai medicine and Yunnan Baiyao all exceed 2 billion yuan, ranking the top five in the list of net profits In the first half of the year, the list of R & D investment of pharmaceutical listed companies was released According to the data, a list of 232 pharmaceutical listed companies' R & D investment in the first half of 2019 was released, with a total of 17.144 billion yuan of R & D investment, of which R & D of Beida pharmaceutical accounted for a high proportion, up to 94.86% Among the top 10 listed pharmaceutical companies with R & D investment, including Beida pharmaceutical, microchip biology, Puli pharmaceutical, Mingde biology, iwuw biology, Kanghong pharmaceutical, shutaishen, Eide biology, Hengrui pharmaceutical and xinlitai The list of top 100 brand enterprises of Chinese medicine in 2018 was released on September 16-17 The press conference of top 100 brand enterprises of Chinese medicine in 2018 was held in Changchun, where the list of top 100 brand enterprises of Chinese medicine in 2018 was released Among them, Yangzijiang Pharmaceutical Co., Ltd ranked first with its flagship product "Lanqin oral liquid", followed by Feining granules of modified Pharmaceutical Co., Ltd and Yunnan Baiyao series products of Yunnan Baiyao The top ten brand enterprises also include step pharmaceutical, Tianshili, Jiangsu Kangyuan, Yiling pharmaceutical, Yifang pharmaceutical, Tongrentang technology and Yibai pharmaceutical China's top 100 strategic emerging industry leaders were released on the morning of September 1, at the 2019 China top 500 enterprises Summit Forum, "China's top 100 strategic emerging industry leaders" was released According to the analysis, in the field of pharmaceutical and biological manufacturing, there are five enterprises on the list, namely Qilu Pharmaceutical (63), Shiyao holding (71), Tianshili (91), Meirui medical (96) and Kangmei Pharmaceutical (98) 12 Chinese enterprises are shortlisted in the top 100 enterprises list published by "bone inquiry - big data of orthopaedics" by the top 100 orthopaedic enterprises in the world Among these 12 Chinese enterprises, 6 enterprises, including natong group, Shanghai minimally invasive orthopedics, Weigao orthopedics, Dabo medical, kailitai orthopedics and Aikang medical, have entered the top 50, which also shows that Chinese orthopedic equipment enterprises are mainly developing comprehensive product lines and are in a high-speed growth period China's top 100 pharmaceutical innovation companies have released "top 100 pharmaceutical innovation companies in China" recently Based on the status quo of pharmaceutical innovation, the list takes enterprises as the main body and hard data as the support, makes an in-depth inventory of the status quo of pharmaceutical industry innovation from three dimensions and four indicators, and selects 100 companies representing China's pharmaceutical innovation strength Among them, the top five companies include Hengrui pharmaceutical, China biopharmaceutical Co., Ltd., Shiyao Holding Group Co., Ltd., Beida Pharmaceutical Co., Ltd and Shanghai Fosun Pharmaceutical (Group) Co., Ltd., which have comprehensive strength and ability to participate in international competition On September 27, the Ministry of industry and information technology issued a notice to announce the list of national technological innovation demonstration enterprises in 2019 A total of 53 enterprises were identified as national technological innovation demonstration enterprises in 2019 In the field of medicine, 9 enterprises including Lepu medical, Guoyao reagent, aosaikang pharmaceutical, Anke biology, Pianzihuang pharmaceutical, Fangsheng pharmaceutical, sannuo biosensor, Yifang pharmaceutical and Laimei pharmaceutical were selected.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.